New ASCO Guidelines App for Phones and Tablets
ASCO has released its Clinical Practice Guidelines as an app so clinicians can keep important information at their fingertips.
Busy clinicians want—and need—information at their fingertips. The American Society of Clinical Oncology (ASCO) just released its Clinical Practice Guidelines as an app that is available to anyone for free (ASCO membership is not required) and available for iOS and Android operating systems.
The "search" mode has both an index and full-text searching capability. Notes can be created from each content screen, which may be a timesaver for information repeatedly accessed. ASCO notes that with its expert recommendations, algorithms, and calculators on the app, decisions can be made more quickly and easily at the point of care.
ASCO also has apps for maintenance of certification or “MOC”, an annual ASCO meeting planner, and ASCO membership directory. The addition of the ASCO Guidelines app is a timely and needed addition to the wealth of resources available to busy clinicians. More information is available here.
FDA Approves T-DXd for Previously Treated HER2-Low and -Ultralow Metastatic Breast Cancer
Published: January 27th 2025 | Updated: January 28th 2025T-DXd has received FDA approval for the treatment of unresectable or metastatic HR+, HER2-low/-ultralow breast cancer in patients whose disease progressed on prior endocrine therapy in the metastatic setting.
ctDNA Status May Be Prognostic for DFS With Celecoxib for Stage III Resected Colon Cancer
January 26th 2025While ctDNA positivity was linked to worse overall disease-free survival (DFS) in stage III resected colon cancer, it was associated with significantly improved DFS with celecoxib compared to placebo.
